Insight Advisors
ABBV icon

Insight Advisors’s AbbVie ABBV Stock Holding History

Insight Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$584K Sell
2,234
-61
-3% -$15.6K 0.1% 124
2026
Q2 		$578K Sell
2,295
-20
-0.9% -$4.3K 0.1% 131
2026
Q1 		$503K Buy
2,315
+21
+0.9% +$4.66K 0.1% 138
2025
Q4 		$524K Sell
2,294
-64
-3% -$14.6K 0.08% 155
2025
Q3 		$546K Sell
2,358
-85
-3% -$17.3K 0.08% 151
2025
Q2 		$453K Sell
2,443
-9
-0.4% -$1.67K 0.07% 165
2025
Q1 		$514K Buy
2,452
+27
+1% +$5.25K 0.09% 142
2024
Q4 		$427K Sell
2,425
-66
-3% -$12.1K 0.07% 179
2024
Q3 		$492K Buy
2,491
+16
+0.6% +$2.99K 0.08% 165
2024
Q2 		$424K Buy
2,475
+148
+6% +$24.5K 0.08% 179
2024
Q1 		$424K Buy
2,327
+7
+0.3% +$1.21K 0.08% 179
2023
Q4 		$360K Sell
2,320
-222
-9% -$32.4K 0.08% 188
2023
Q3 		$379K Buy
2,542
+53
+2% +$7.78K 0.09% 174
2023
Q2 		$335K Buy
2,489
+394
+19% +$57.8K 0.07% 195
2023
Q1 		$334K Sell
2,095
-752
-26% -$115K 0.08% 206
2022
Q4 		$462K Sell
2,847
-1,654
-37% -$254K 0.16% 171
2022
Q3 		$604K Sell
4,501
-8
-0.2% -$1.15K 0.24% 109
2022
Q2 		$634K Sell
4,509
-1,708
-27% -$261K 0.22% 121
2022
Q1 		$1.01M Buy
6,217
+2,373
+62% +$345K 0.3% 93
2021
Q4 		$520K Buy
3,844
+1,813
+89% +$214K 0.15% 167
2021
Q3 		$238K Sell
2,031
-11
-0.5% -$1.26K 0.07% 276
2021
Q2 		$236K Sell
2,042
-522
-20% -$58.8K 0.07% 276
2021
Q1 		$287K Buy
2,564
+375
+17% +$40.1K 0.09% 266
2020
Q4 		$235K Buy
+2,189
New +$210K 0.09% 239

Other funds holding ABBV

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Cardano Risk Management
Cardano Risk Management Rotterdam, Netherlands $18.2B AUM 38.97% 1-Year Est. Return
Sepio Capital
Sepio Capital Salt Lake City, Utah $2.5B AUM 20.77% 1-Year Est. Return
Hamlin Capital Management
Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Ferguson Wellman Capital Management
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return
ABN AMRO Investment Solutions
ABN AMRO Investment Solutions Paris Cedex 008 $13.2B AUM 30.55% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Insight Advisors's ABBV Position: Q3 2026 in Review

Insight Advisors reduced its AbbVie (ABBV) stake by 2.7% in Q3 2026, selling an estimated $15.6K and leaving 2,234 shares worth $584K. The position accounts for 0.1% of the portfolio, ranked #124.

Insight Advisors first reported a position in ABBV in Q4 2020 and has held it in 24 quarters since. The position peaked at $1.01M in Q1 2022. 1,436 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Insight Advisors held 2,234 shares of AbbVie worth $584K as of Q3 2026.
  • Insight Advisors sold 61 AbbVie shares in Q3 2026, an estimated $15.6K.
  • AbbVie made up 0.1% of Insight Advisors's portfolio in Q3 2026, its #124 holding.
  • Insight Advisors first reported a position in AbbVie in Q4 2020 and has held it in 24 quarters since.
  • Insight Advisors's AbbVie position peaked at $1.01M in Q1 2022.
  • 1,436 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Insight Advisors's 13F filing for Q3 2026, filed 22 Oct 2026.